Pan-Lin Capital
Asia, Shanghai, China, Shanghai'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Pan-Lin Capital primarily investing in tech startups at series pre-A and A rounds.
Investor Profile
Pan-Lin Capital has backed more than 13 startups, with 4 new investments in the last 12 months alone. The firm has led 4 rounds, about 31% of its total and boasts 4 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Seed rounds (top funding stages).
- Majority of deals are located in China, United States.
- Strong thematic focus on Health Care, Biotechnology, Medical.
- Led 1 rounds in the past year.
Stage Focus
- Series B (31%)
- Series A (31%)
- Seed (23%)
- Series C (8%)
- Angel (8%)
Country Focus
- China (92%)
- United States (8%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Genetics
- Oncology
- Pharmaceutical
- Cloud Computing
- Cloud Data Services
- Cloud Infrastructure
- Software
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(144 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(216 450 300)'/%3e%3cuse xlink:href='%23a' transform='rotate(288 450 300)'/%3e%3c/svg%3e)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
